A programmable CRISPR/dCas9-based epigenetic editing system enabling loci-targeted histone citrullination and precise transcription regulation
Open Access
- 6 June 2024
- journal article
- research article
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 51 (12) , 1485-1493
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Peptidylarginine deiminase-4: Medico-formulative strategy towards management of rheumatoid arthritisBiochemical Pharmacology, 2022
- The roles of PAD2‐ and PAD4‐mediated protein citrullination catalysis in cancersInternational Journal of Cancer, 2020
- TALEN-Mediated Mutagenesis and Genome Editing2016
- Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA ScaffoldsCell, 2015
- SnapShot: Histone ModificationsCell, 2014
- Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesisBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2013
- Chromatin Modifications and Their FunctionCell, 2007
- Citrullination: A posttranslational modification in health and diseaseThe International Journal of Biochemistry & Cell Biology, 2006
- Almost all about citrulline in mammalsAmino Acids, 2005
- PAD, a growing family of citrullinating enzymes: genes, features and involvement in diseaseBioEssays, 2003